BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20841334)

  • 1. Estimation and selection in high-dimensional genomic studies for developing molecular diagnostics.
    Matsui S; Noma H
    Biostatistics; 2011 Apr; 12(2):223-33. PubMed ID: 20841334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian ranking and selection methods using hierarchical mixture models in microarray studies.
    Noma H; Matsui S; Omori T; Sato T
    Biostatistics; 2010 Apr; 11(2):281-9. PubMed ID: 19946026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GMM-IG framework for selecting genes as expression panel biomarkers.
    Wang M; Chen JY
    Artif Intell Med; 2010; 48(2-3):75-82. PubMed ID: 20004087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical Bayes ranking and selection methods via semiparametric hierarchical mixture models in microarray studies.
    Noma H; Matsui S
    Stat Med; 2013 May; 32(11):1904-16. PubMed ID: 23281021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating effect sizes of differentially expressed genes for power and sample-size assessments in microarray experiments.
    Matsui S; Noma H
    Biometrics; 2011 Dec; 67(4):1225-35. PubMed ID: 21627629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Markov random field model for network-based analysis of genomic data.
    Wei Z; Li H
    Bioinformatics; 2007 Jun; 23(12):1537-44. PubMed ID: 17483504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles.
    Kendziorski CM; Newton MA; Lan H; Gould MN
    Stat Med; 2003 Dec; 22(24):3899-914. PubMed ID: 14673946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian variable selection for the analysis of microarray data with censored outcomes.
    Sha N; Tadesse MG; Vannucci M
    Bioinformatics; 2006 Sep; 22(18):2262-8. PubMed ID: 16845144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarrays: applications in genomic research.
    Watanabe A; Cornelison R; Hostetter G
    Expert Rev Mol Diagn; 2005 Mar; 5(2):171-81. PubMed ID: 15833047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-class predictor based on a probabilistic model: application to gene expression profiling-based diagnosis of thyroid tumors.
    Yukinawa N; Oba S; Kato K; Taniguchi K; Iwao-Koizumi K; Tamaki Y; Noguchi S; Ishii S
    BMC Genomics; 2006 Jul; 7():190. PubMed ID: 16872506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric pathway-based regression models for analysis of genomic data.
    Wei Z; Li H
    Biostatistics; 2007 Apr; 8(2):265-84. PubMed ID: 16772399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models.
    Matsui S; Ito M; Nishiyama H; Uno H; Kotani H; Watanabe J; Guilford P; Reeve A; Fukushima M; Ogawa O
    Bioinformatics; 2007 Mar; 23(6):732-8. PubMed ID: 17237045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data.
    Shedden K; Chen W; Kuick R; Ghosh D; Macdonald J; Cho KR; Giordano TJ; Gruber SB; Fearon ER; Taylor JM; Hanash S
    BMC Bioinformatics; 2005 Feb; 6():26. PubMed ID: 15705192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian approach to estimation and testing in time-course microarray experiments.
    Angelini C; De Canditiis D; Mutarelli M; Pensky M
    Stat Appl Genet Mol Biol; 2007; 6():Article24. PubMed ID: 17910530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic test bed for feature selection.
    Choudhary A; Brun M; Hua J; Lowey J; Suh E; Dougherty ER
    Bioinformatics; 2006 Apr; 22(7):837-42. PubMed ID: 16428263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of human cancer type by gene expression profiles and independent component analysis.
    Zhang XW; Yap YL; Wei D; Chen F; Danchin A
    Eur J Hum Genet; 2005 Dec; 13(12):1303-11. PubMed ID: 16205741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.